KR102286593B1 - Manufacturing method of health functional food for cognitive function improvement that can help prevent dementia symptoms and health functional food - Google Patents
Manufacturing method of health functional food for cognitive function improvement that can help prevent dementia symptoms and health functional food Download PDFInfo
- Publication number
- KR102286593B1 KR102286593B1 KR1020190105027A KR20190105027A KR102286593B1 KR 102286593 B1 KR102286593 B1 KR 102286593B1 KR 1020190105027 A KR1020190105027 A KR 1020190105027A KR 20190105027 A KR20190105027 A KR 20190105027A KR 102286593 B1 KR102286593 B1 KR 102286593B1
- Authority
- KR
- South Korea
- Prior art keywords
- sorghum
- hours
- health functional
- functional food
- temperature
- Prior art date
Links
- 230000036541 health Effects 0.000 title claims abstract description 38
- 235000013376 functional food Nutrition 0.000 title claims abstract description 35
- 206010012289 Dementia Diseases 0.000 title claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 18
- 230000003920 cognitive function Effects 0.000 title claims abstract description 15
- 208000024891 symptom Diseases 0.000 title claims abstract description 15
- 230000006872 improvement Effects 0.000 title description 2
- 240000006394 Sorghum bicolor Species 0.000 claims abstract description 49
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims abstract description 49
- 239000000284 extract Substances 0.000 claims abstract description 30
- 239000007788 liquid Substances 0.000 claims abstract description 24
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 20
- 229910001018 Cast iron Inorganic materials 0.000 claims abstract description 19
- 230000032683 aging Effects 0.000 claims abstract description 18
- 238000010438 heat treatment Methods 0.000 claims abstract description 18
- 235000020556 functional concentrate Nutrition 0.000 claims abstract description 16
- 244000062793 Sorghum vulgare Species 0.000 claims abstract description 14
- 235000019713 millet Nutrition 0.000 claims abstract description 14
- 238000000855 fermentation Methods 0.000 claims abstract description 11
- 230000004151 fermentation Effects 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims abstract description 8
- 244000042664 Matricaria chamomilla Species 0.000 claims abstract description 8
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract description 8
- 240000007594 Oryza sativa Species 0.000 claims abstract description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 8
- 238000001914 filtration Methods 0.000 claims abstract description 8
- 239000004615 ingredient Substances 0.000 claims abstract description 8
- 235000009566 rice Nutrition 0.000 claims abstract description 8
- 238000005406 washing Methods 0.000 claims abstract description 8
- 239000011347 resin Substances 0.000 claims abstract description 6
- 229920005989 resin Polymers 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 241001105098 Angelica keiskei Species 0.000 claims abstract description 3
- 240000005979 Hordeum vulgare Species 0.000 claims abstract 5
- 239000000843 powder Substances 0.000 claims description 7
- 229940030961 sorghum extract Drugs 0.000 claims description 7
- 240000002045 Guettarda speciosa Species 0.000 claims description 4
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 2
- 229940027779 persimmon extract Drugs 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 abstract description 12
- 230000003078 antioxidant effect Effects 0.000 abstract description 12
- 230000006993 memory improvement Effects 0.000 abstract description 8
- 239000004480 active ingredient Substances 0.000 abstract description 6
- 230000002265 prevention Effects 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 201000010099 disease Diseases 0.000 description 16
- 241000209219 Hordeum Species 0.000 description 15
- 230000035882 stress Effects 0.000 description 12
- 239000003814 drug Substances 0.000 description 6
- 230000003938 response to stress Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 4
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000011888 snacks Nutrition 0.000 description 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 2
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 102400000739 Corticotropin Human genes 0.000 description 2
- 101800000414 Corticotropin Proteins 0.000 description 2
- 208000026139 Memory disease Diseases 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 210000001943 adrenal medulla Anatomy 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000003930 cognitive ability Effects 0.000 description 2
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 2
- 229960000258 corticotropin Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 210000001320 hippocampus Anatomy 0.000 description 2
- 210000003016 hypothalamus Anatomy 0.000 description 2
- 230000013016 learning Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000008897 memory decline Effects 0.000 description 2
- 230000006984 memory degeneration Effects 0.000 description 2
- 208000023060 memory loss Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000002820 sympathetic nervous system Anatomy 0.000 description 2
- 229960001685 tacrine Drugs 0.000 description 2
- YLJREFDVOIBQDA-UHFFFAOYSA-N tacrine Chemical compound C1=CC=C2C(N)=C(CCCC3)C3=NC2=C1 YLJREFDVOIBQDA-UHFFFAOYSA-N 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- 208000000103 Anorexia Nervosa Diseases 0.000 description 1
- 241000937413 Axia Species 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 206010065941 Central obesity Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- 102000012289 Corticotropin-Releasing Hormone Human genes 0.000 description 1
- 108010022152 Corticotropin-Releasing Hormone Proteins 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- GMZVRMREEHBGGF-UHFFFAOYSA-N Piracetam Chemical compound NC(=O)CN1CCCC1=O GMZVRMREEHBGGF-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 229940005524 anti-dementia drug Drugs 0.000 description 1
- 229940039856 aricept Drugs 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 208000013404 behavioral symptom Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 230000007052 brain toxicity Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 231100000976 cerebrotoxicity Toxicity 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 230000010485 coping Effects 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229960003530 donepezil Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004179 hypothalamic–pituitary–adrenal axis Effects 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003446 memory effect Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 208000019906 panic disease Diseases 0.000 description 1
- 229960004526 piracetam Drugs 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/51—Concentration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/152—Cereal germ products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/20—Malt products
- A23L7/25—Fermentation of cereal malt or of cereal by malting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B25/00—Packaging other articles presenting special problems
- B65B25/001—Packaging other articles presenting special problems of foodstuffs, combined with their conservation
Abstract
본 발명은 치매 증상 예방에 도움을 줄 수 있는 인지기능 개선용 건강기능식품의 제조방법 및 그 건강기능식품에 관한 것으로 기억력 증진 및 항산화에 효과가 있다고 알려진 참당귀, 석창포, 초석잠, 수수, 보리엿기름에 포함된 유효성분을 극대화하여 항산화, 기억력 증진, 치매예방에 도움을 줄 수 있도록 하기 위하여, 참당귀, 석창포, 초석잠, 수수 및 보리엿기름을 준비하는 원재료 준비단계(S1); 상기 참당귀, 석창포 및 초석잠을 무쇠가마솥에서 130∼145℃의 온도로 2∼2.5시간 동안 가열하여 추출액을 제조하는 단계(S2); 상기 수수를 세척한 후 무쇠가마솥에 볶은 다음, 100∼115℃의 온도로 1.5∼2시간 동안 가열하여 추출액과 건더기로 분리 여과하는 단계(S3); 상기 S2 및 S3단계를 통해 제조된 참당귀, 석창포, 초석잠 및 수수의 추출액을 4∼6℃에서 20∼24시간 동안 1차 저온숙성발효하여 1차발효액을 제조하는 단계(S4); 상기 S4단계를 통해 제조된 1차발효액을 -3∼-1℃에서 10∼13시간 동안 2차 저온냉동숙성발효하여 2차발효액을 제조하는 단계(S5); 상기 S2단계를 통해 제조된 수수건더기를 무쇠가마솥에 넣고 가열하여 수수지에밥을 지은 후, 보리엿기름을 넣고 발효하여 수수식혜를 제조하는 단계(S6); 상기 2차발효액과 수수식혜를 각각 여과하여 혼합한 후, 75∼85℃의 온도로 7∼10시간 동안 가열하여 기능성 농축액을 제조하는 단계(S7);를 포함하여 이루어지는 것을 특징으로 한다.The present invention relates to a method for manufacturing a health functional food for improving cognitive function, which can help prevent dementia symptoms, and a health functional food therefor. In order to maximize the active ingredients contained in malt to help antioxidant, memory enhancement, and dementia prevention, raw material preparation step (S1) of preparing sorghum and barley malt; Preparing the extract (S2) by heating the chamomile, seokchangpo and choseokjam in a cast iron cauldron at a temperature of 130 to 145° C. for 2 to 2.5 hours; After washing the sorghum, roasting it in a cast iron cauldron, heating it at a temperature of 100 to 115° C. for 1.5 to 2 hours, and separating and filtering the extract and the ingredients (S3); Preparing a primary fermented liquid by first aging and fermenting the extracts of Angelica keiskei, seokchangpo, choseokjam and sorghum prepared through the steps S2 and S3 at 4 to 6° C. for 20 to 24 hours (S4); preparing a secondary fermented liquid by secondary low-temperature freeze-aging fermentation of the primary fermented liquid prepared in step S4 at -3 to -1°C for 10 to 13 hours (S5); Putting the millet pieces prepared in step S2 in a cast iron cauldron and heating to cook rice in resin, then adding barley malt and fermenting to prepare millet sikhye (S6); After filtering and mixing the secondary fermentation broth and millet sikhye, respectively, heating at a temperature of 75 to 85° C. for 7 to 10 hours to prepare a functional concentrate (S7); characterized in that it comprises a.
Description
본 발명은 치매 증상 예방에 도움을 줄 수 있는 인지기능 개선용 건강기능식품의 제조방법 및 그 건강기능식품에 관한 것으로서, 보다 상세하게는 기억력 증진 및 항산화에 효과가 있다고 알려진 참당귀, 석창포, 초석잠, 수수, 보리엿기름에 포함된 유효성분을 극대화하여 항산화, 기억력 증진, 치매예방에 도움을 줄 수 있는 인지기능 개선용 건강기능식품의 제조방법 및 그 건강기능식품에 관한 것이다.The present invention relates to a method for manufacturing a health functional food for improving cognitive function, which can help prevent dementia symptoms, and a health functional food therefor, and more particularly, to improve memory and antioxidant effect. It relates to a method for manufacturing a health functional food for improving cognitive function, which can help antioxidant, memory enhancement, and dementia prevention by maximizing active ingredients contained in sleep, sorghum, and barley malt, and health functional food.
최근 사회구조가 급변하면서, 사회 생활을 통해 스트레스성 질환 및 노화의 가속화 등으로 노화 및 노화와 관련된 다양한 질병 혹은 질환으로 인하여, 많은 의료비용이 발생하고, 이러한 의료비 증가가 사회적 비용 증가로 연결되고 있다. 노화와 관련된 질환 중에서도 특히 노인성 뇌질환(치매)은 최근 들어, 노인 질환 중에서도 대표적인 질환으로 손꼽히고 있다. 또한, 학업에 시달리는 청소년, 각종 취업으로 인한 입사시험, 사회 참여의 다양화를 위해 각종 자격 시험을 준비하는 사회 참여 인구의 증가, 평생 교육의 확대로 인한 중장년층의 교육활동 등이 확대되면서, 뇌를 많이 사용하는 인구가 폭발적으로 증가하고 있고, 이로 인하여, 노화의 진행에 따른 치매에 대한 관심도 매우 증가하게 되었다. 이를 해결하기 위하여, 다양한 건강기능식품, 특히, 가바(GABA, Gamma amino butyric acid)나, 포스파티딜세린(Phosphatidylserine) 등의 건강식품 소재가 개발되었으며, 두뇌의 기능을 조절하는 약물로서, 지각능력을 증진시키고, 두뇌의 노화를 늦추는 효과가 있는 것으로 알려진 피라세탐(Piracetam)이라는 의약품도 시판되고 있다.Recently, as the social structure is rapidly changing, due to various diseases or diseases related to aging and aging due to stress-related diseases and acceleration of aging through social life, a lot of medical expenses are incurred, and this increase in medical expenses is connected to increase in social costs. . Among the diseases associated with aging, senile brain disease (dementia) has recently been considered as a representative disease among the diseases of the elderly. In addition, as the number of adolescents suffering from studies, entrance exams for various jobs, the increase in the social participation population preparing for various qualification tests to diversify social participation, and the educational activities of middle-aged people due to the expansion of lifelong education expand, the brain The number of people who use it is increasing explosively, and due to this, interest in dementia according to the progress of aging has also increased significantly. In order to solve this problem, various health functional foods, in particular, health food materials such as GABA (Gamma amino butyric acid) and phosphatidylserine have been developed. A drug called Piracetam, which is known to have the effect of slowing the aging of the brain, is also on the market.
일반적으로 항산화와 기억력 감퇴는 정상적인 활동에 많은 어려움을 주고, 항산화는 각종질병의 원인이 되며, 특히 기억력 감퇴는 우리의 뇌가 각종질환으로 지적능력을 상실하여 본인이 체험한 일중 일부분을 잊어버리거나 행동장애, 기억력장애, 판단장애 등을 나타내는데 이를 치매증상이라 한다.In general, antioxidant and memory loss cause many difficulties in normal activities, and antioxidant is the cause of various diseases. Disability, memory impairment, judgment impairment, etc. are referred to as dementia symptoms.
이러한 치매는 다양한 원인으로 발병할 수 있으나, 알츠하이머성 치매가 노인성 치매 중 가장 많은 부분을 차지하고 있으며 주요 발병요인은 베타아밀로이드(Ab1-42)의 뇌내 축적과 그로 인한 신경 독성이 발병의 매우 중요한 원인으로 알려져 있으며[Selkoe, Annu Rev Neurosci, 17, 489-517(1994)], 기타 다른 요인들도 거론되고 있다. 결국, 치매의 근본적인 원인은 노화와 더불어서 발생되는 각종 세포 내 독성에 의한 신경세포의 활성저하 및 사멸에 있다. 그러나 현재까지 알려진 치매 치료제(tacrine, Cognex; Donepezil, Aricept)들은 신경전달 물질인 아세틸콜린(acetylcholine)의 작용을 증진시키는 것들로서 치매의 증상이 어느 정도 완화될 수는 있지만 여러가지 부작용(간 독성, 구토, 설사 등)이 문제점으로 알려져 있다.Such dementia can be caused by various causes, but Alzheimer's dementia accounts for the largest portion of senile dementia, and the main cause is the accumulation of beta-amyloid (Ab1-42) in the brain and neurotoxicity as a very important cause of the onset. is known [Selkoe, Annu Rev Neurosci, 17, 489-517 (1994)], and other factors have also been discussed. After all, the root cause of dementia lies in the decrease in activity and death of nerve cells due to various intracellular toxins that occur along with aging. However, the currently known anti-dementia drugs (tacrine, Cognex; Donepezil, Aricept) enhance the action of the neurotransmitter acetylcholine. , diarrhea, etc.) are known to be a problem.
그리고, 스트레스는 모든 병의 근원으로 인체의 부조화와 순환장애 등을 유발하여 질병의 원인으로 작용한다. 인체가 스트레스를 받게 되면 자신을 보호하기 위해 시상하부-뇌하수체-부신계(Hypothalamus-Pituitary-Adrenal, HPA axis) 및 부신수질 및 교감신경계의 항진으로 에피네프린(epinephrine) 및 노어에피네프린(norepinephrine)의 분비를 증강시키며 시상하부에서 코티코트로핀 분비인자(corticotropin releasing factor) 분비 증가, 뇌하수체 전엽에서 부신피질자극호르몬(adrenocorticotropic hormone, ACTH) 분비증가, 부신수질에서 코티코스테론(corticosterone), 알도스테론(aldosterone) 등의 분비를 증가시켜 스트레스 반응을 나타낸다. 스트레스 반응에는 혈압상승, 심박동수 증가, 행동변화, 위장관으로부터 골격근으로의 혈액 이동, 비장무게의 감소, 백혈구수 감소로 인한 면역력 감소 등이 있다. 스트레스의 정도가 크고 오랫동안 받게 되거나 우리 인체의 스트레스 반응시스템에 결함이 있으면 병으로 연결된다. 스트레스 반응을 수행하는 시상하부-뇌하수체-부신계(HPA axia) 및 교감신경의 항진은 심각한 만성질환, 우울증, 신경성 식욕감퇴, 망상-강박장애, 공황장애, 당뇨병, 갑상선기능 항진, 중심성 비만, 고혈압, 심장병 같은 질병을 초래한다.And, as the source of all diseases, stress causes imbalance and circulation disorders in the human body, thereby acting as a cause of disease. When the body is under stress, the hypothalamus-Pituitary-Adrenal (HPA axis), adrenal medulla and sympathetic nervous system are stimulated to release epinephrine and norepinephrine to protect themselves. Increases the secretion of corticotropin releasing factor from the hypothalamus, increases the secretion of adrenocorticotropic hormone (ACTH) from the anterior pituitary, and increases the secretion of corticosterone and aldosterone from the adrenal medulla. It increases secretion to indicate a stress response. Stress responses include increased blood pressure, increased heart rate, behavioral changes, blood movement from the gastrointestinal tract to skeletal muscle, decreased spleen weight, and decreased immunity due to decreased white blood cell count. If the degree of stress is large and prolonged, or if our body's stress response system is defective, it leads to illness. Hypertension of the hypothalamus-pituitary-adrenal system (HPA axia) and sympathetic nervous system, which carries out the stress response, is a serious chronic disease, depression, anorexia nervosa, delusional-obsessive compulsive disorder, panic disorder, diabetes, hyperthyroidism, central obesity, hypertension. , leading to diseases such as heart disease.
또한, 소음, 공해, 불안상태나 억울 등 과도한 스트레스는 면역능력에 영향을 미쳐 생체에 저항능력을 억제하여 감염, 자가면역 및 뇌의 퇴행성 질환 등 각종 질병을 일으키는 것으로 알려지면서, 스트레스의 발병기전에 심혈관계, 내분비계와 더불어 면역계의 역할에 연구의 초점이 모아지고 있다. 면역계에서 중요한 역할을 하는 사이토킨(cytokine)이 스트레스 반응을 조절하여 스트레스성 질환을 유발시키는 것으로 알려져 있다. 즉, 시상하부(hypothalamus)와 해마(hippocampus)를 비롯한 중추신경계 내에서 사이토킨의 방출은 국소 염증반응을 일으켜 인체에 매우 해로운 요소로 작용할 수 있다. 장기간의 스트레스에 노출되면 해마 내 신경세포의 소실이 오며 학습과 기억에 심각한 영향을 미친다. 하지만, 스트레스에 의한 사이토킨의 방출과 학습, 기억 소실 및 불안 등의 스트레스 반응과의 관련성에 대한 연구가 진행중이나 아직 그 기전과 역할이 잘 알려져 있진 않고 있다. 유기체가 살아가면서 접하게 되는 환경적인 스트레스를 통제한다는 것이 실제로 불가능하며, 스트레스와 관련된 여러 질환이 급등하는 현실을 감안할 때, 스트레스에 대한 면역계의 반응으로 나타나는 행동증상의 기전을 이해하는 것은 우리가 스트레스에 대처하는데 많은 도움을 줄 것이다. 따라서, 스트레스의 중추성 면역학적 기전을 밝혀 새로운 약물 및 치료방법의 개발에 필요한 이론적인 배경을 제공하는 연구가 절실히 요구되고 있다.In addition, excessive stress, such as noise, pollution, anxiety, or unfairness, affects the immune system and suppresses the body's resistance to cause various diseases such as infection, autoimmunity, and degenerative diseases of the brain. Research has focused on the role of the immune system along with the cardiovascular and endocrine systems. Cytokines, which play an important role in the immune system, are known to induce stress-related diseases by regulating the stress response. That is, the release of cytokines in the central nervous system including the hypothalamus and hippocampus can cause a local inflammatory reaction and act as a very harmful element to the human body. Long-term exposure to stress leads to loss of neurons in the hippocampus, severely affecting learning and memory. However, although studies on the relationship between the release of cytokines by stress and stress responses such as learning, memory loss and anxiety are ongoing, the mechanism and role are not well known. Given the fact that it is virtually impossible to control the environmental stress that an organism encounters in life, and the number of stress-related diseases is soaring, it is important to understand the mechanism of behavioral symptoms that appear as a response of the immune system to stress. It will help you a lot in coping. Therefore, there is an urgent need for research to provide a theoretical background for the development of new drugs and treatment methods by revealing the central immunological mechanism of stress.
이에 따라 최근 들어, 기존의 의학을 대체한 천연물 및 기타 요법을 이용한 대체의학이 강조되면서, 천연물을 이용한 천연물 의약품 혹은 건강기능식품에 대한 관심이 높아지고 있다. 실제로 천연물 신약과 천연물 개별인정형 건강식품의 제품 개발이 매우 활발하게 진행되고 있으며, 이에 따라 기존의 의학으로 쉽게 접근하지 못했던 분야에 대한 연구도 활발히 진행되고 있다. 앞서 언급한 바와 같이 사회구조가 급변하면서, 사회 생활을 통해 스트레스성 질환 및 노화의 가속화 등으로 노화 및 노화와 관련된 다양한 질병 혹은 질환을 효율적으로 치료하기 위해, 기존의 방법에 비하여 부작용이 적으면서도 효과는 더욱 뛰어날 것으로 알려진 천연물 의약품 혹은 건강기능식품에 대한 개발이 필요한 실정이다.Accordingly, in recent years, with emphasis on alternative medicine using natural products and other therapies that have replaced conventional medicine, interest in natural medicines or health functional foods using natural products is increasing. In fact, the development of natural new drugs and health food products that are individually recognized for natural products is being actively carried out, and research into fields that have not been easily accessed by conventional medicine is being actively conducted. As mentioned above, in order to efficiently treat various diseases or diseases related to aging and aging due to stress-related diseases and acceleration of aging through social life as the social structure changes rapidly, it is effective with fewer side effects compared to existing methods. There is a need to develop natural medicines or health functional foods that are known to be even better.
따라서 본 출원인은 치매의 주요 증상인 기억력 감퇴 및 인지능력을 개선하는데 효능이 있는 재료를 활용하여 일상생활에서 편하게 섭취할 수 있도록 스틱형 및 스낵 형태로 된 건강기능제품을 제안하고자 한다.Therefore, the present applicant intends to propose health functional products in the form of sticks and snacks so that they can be conveniently consumed in daily life by utilizing ingredients effective in improving memory decline and cognitive ability, which are the main symptoms of dementia.
이에 본 발명은 상기한 문제점을 일소하기 위해 창안한 것으로서, 기억력 증진 및 항산화에 효과가 있다고 알려진 참당귀, 석창포, 초석잠, 수수, 보리엿기름에 포함된 유효성분을 극대화하여 항산화, 기억력 증진, 치매예방에 도움을 줄 수 있도록 하는 치매 증상 예방에 도움을 줄 수 있는 인지기능 개선용 건강기능식품의 제조방법 및 그 건강기능식품에 주안점을 두고 그 기술적 과제로서 완성한 것이다.Accordingly, the present invention was devised to eliminate the above-mentioned problems, and maximizes the active ingredients contained in chamomile, seokchangpo, choseokjam, sorghum, and barley malt, which are known to be effective in improving memory and antioxidants, thereby providing antioxidant, memory enhancement, and dementia. It was completed as a technical task with a focus on the manufacturing method of a health functional food for improving cognitive function that can help prevent dementia symptoms that can help prevent it, and the health functional food.
위 기술적 과제를 달성하기 위한 본 발명은, 참당귀, 석창포, 초석잠, 수수 및 보리엿기름을 준비하는 원재료 준비단계(S1); 상기 참당귀, 석창포 및 초석잠을 무쇠가마솥에서 130∼145℃의 온도로 2∼2.5시간 동안 가열하여 추출액을 제조하는 단계(S2); 상기 수수를 세척한 후 무쇠가마솥에 볶은 다음, 100∼115℃의 온도로 1.5∼2시간 동안 가열하여 추출액과 건더기로 분리 여과하는 단계(S3); 상기 S2 및 S3단계를 통해 제조된 참당귀, 석창포, 초석잠 및 수수의 추출액을 4∼6℃에서 20∼24시간 동안 1차 저온숙성발효하여 1차발효액을 제조하는 단계(S4); 상기 S4단계를 통해 제조된 1차발효액을 -3∼-1℃에서 10∼13시간 동안 2차 저온냉동숙성발효하여 2차발효액을 제조하는 단계(S5); 상기 S3단계를 통해 제조된 수수건더기를 무쇠가마솥에 넣고 가열하여 수수지에밥을 지은 후, 보리엿기름을 넣고 발효하여 수수식혜를 제조하는 단계(S6); 상기 2차발효액과 수수식혜를 각각 여과하여 혼합한 후, 75∼85℃의 온도로 7∼10시간 동안 가열하여 기능성 농축액을 제조하는 단계(S7);를 포함하여 이루어지는 치매 증상 예방에 도움을 줄 수 있는 인지기능 개선용 건강기능식품의 제조방법에 있어서, 상기 S2단계 및 S3단계를 통해 제조된 추출액은 참당귀추출액 31∼37중량%, 석창포추출액 25∼34중량%, 초석잠추출액 19∼27중량% 및 수수추출액 8∼12중량%로 이루어지고, 상기 S6단계의 수수식혜를 제조하는 단계에서 수수지에밥 100중량부를 기준으로 보리엿기름 21∼25중량부를 혼합한 후, 58∼63℃에서 8∼10시간 동안 발효하여 수수식혜를 제조하며, 상기 S7단계를 통해 제조된 기능성 농축액에 수수가루를 혼합, 발효하여 강정과 양갱 중간형태의 디저트형 건강기능식품을 제조하되, 상기 디저트형 건강기능식품을 제조 시, 상기 기능성 농축액 100중량부를 기준으로 수수가루 30∼32중량부를 혼합한 후, 40∼43℃의 온도에서 12∼14시간 동안 발효한 다음, 5∼8℃의 온도에서 6∼7시간 동안 저온건조하여 완성되도록 구성하는 것을 기술적 특징으로 한다.The present invention for achieving the above technical task, the raw material preparation step (S1) to prepare chamsanggui, seokchangpo, choseokjam, sorghum and barley malt; Preparing the extract (S2) by heating the chamanggui, seokchangpo and choseokjam in a cast iron cauldron at a temperature of 130 to 145° C. for 2 to 2.5 hours; After washing the sorghum, roasting it in a cast iron cauldron, heating it at a temperature of 100 to 115° C. for 1.5 to 2 hours, and separating and filtering the extract and the ingredients (S3); Preparing a primary fermented liquid by first aging and fermenting the extracts of Angelica serrata, seokchangpo, choseokjam and sorghum prepared through the steps S2 and S3 at 4∼6°C for 20∼24 hours (S4); preparing a secondary fermented liquid by performing secondary low-temperature freezing and aging fermentation of the primary fermented liquid prepared in step S4 at -3 to -1°C for 10 to 13 hours (S5); Putting the millet pieces prepared in step S3 in a cast iron cauldron and heating to cook rice in resin, then adding barley malt and fermenting to prepare millet sikhye (S6); After filtering and mixing the secondary fermented liquid and sorghum sikhye, respectively, heating at a temperature of 75 to 85 ° C for 7 to 10 hours to prepare a functional concentrate (S7); In the method for producing health functional food for improving cognitive function, the extract prepared through steps S2 and S3 is 31 to 37% by weight of Angelica perilla extract, 25 to 34% by weight of seokchangpo extract, 19 to 27 It consists of weight % and 8 to 12 weight % of sorghum extract, and after mixing 21 to 25 parts by weight of barley malt based on 100 parts by weight of sorghum in the step of preparing sorghum sikhye in step S6, 8 to at 58 to 63 ° C. It is fermented for 10 hours to produce sorghum sikhye, and by mixing and fermenting sorghum powder in the functional concentrate prepared in step S7, a dessert-type health functional food intermediate between gangjeong and yanggaeng is produced, but the dessert-type health functional food is In manufacturing, 30 to 32 parts by weight of sorghum powder are mixed based on 100 parts by weight of the functional concentrate, then fermented at a temperature of 40 to 43° C. for 12 to 14 hours, and then at a temperature of 5 to 8° C. for 6 to 7 hours. It is characterized in that it is configured to be completed by drying at a low temperature.
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
상기한 본 발명에 의하면 기억력 증진 및 항산화에 효과가 있다고 알려진 참당귀, 석창포, 초석잠, 수수, 보리엿기름에 포함된 유효성분을 극대화하여 항산화, 기억력 증진, 치매예방에 도움을 줄 수 있고, 치매의 주요 증상인 기억력 감퇴 및 인지능력을 개선하는데 효능이 있는 재료를 활용하여 스틱형 및 스낵 형태로 된 건강기능제품을 개발함으로써 소비자가 일상생활에서 편하게 섭취할 수 있도록 하는 효과가 있다.According to the present invention as described above, it can help antioxidant, memory enhancement, and dementia prevention by maximizing the active ingredients contained in chamomile, seokchangpo, choseokjam, sorghum, and barley malt, which are known to be effective in memory enhancement and antioxidant, and dementia. Developing health functional products in the form of sticks and snacks using ingredients that are effective in improving memory decline and cognitive ability, which are the main symptoms of
삭제delete
도 1 및 도 2는 본 발명에 의한 치매 증상 예방에 도움을 줄 수 있는 인지기능 개선용 건강기능식품의 제조방법의 공정 순서 예시도1 and 2 are an exemplary process flow diagram of a method for manufacturing a health functional food for improving cognitive function that can help prevent dementia symptoms according to the present invention
이하 본 발명의 실시를 위한 구체적인 내용을 첨부한 도면을 참조하여 더욱 상세하게 설명한다.Hereinafter, specific contents for carrying out the present invention will be described in more detail with reference to the accompanying drawings.
본 발명은 기억력 증진 및 항산화에 효과가 있다고 알려진 참당귀, 석창포, 초석잠, 수수, 보리엿기름에 포함된 유효성분을 극대화하여 항산화, 기억력 증진 및 치매 증상 예방에 도움을 줄 수 있는 인지기능 개선용 건강기능식품의 제조방법 및 그 건강기능식품에 관한 것으로서 도 1 및 도 2를 참고하여 보면 원재료 준비단계(S1), 참당귀, 석창포 및 초석잠의 추출액을 제조하는 단계(S2), 수수를 추출액과 건더기로 분리 여과하는 단계(S3), 참당귀, 석창포, 초석잠 및 수수의 추출액을 발효하여 1차발효액을 제조하는 단계(S4), 1차발효액을 발효하여 2차발효액을 제조하는 단계(S5), 수수건더기에 보리엿기름을 넣고 수수식혜를 제조하는 단계(S6) 및 2차발효액과 수수식혜를 혼합하여 기능성 농축액을 제조하는 단계(S7)를 포함하여 이루어지며 보다 상세하게 설명하면 아래와 같다.The present invention is for improving cognitive function that can help antioxidant, memory enhancement and prevention of dementia symptoms by maximizing the active ingredients contained in chamomile, seokchangpo, choseokjam, sorghum, and barley malt, which are known to be effective in memory enhancement and antioxidant As relates to a method for manufacturing a health functional food and a health functional food therefor, referring to FIGS. 1 and 2 , the raw material preparation step (S1), the step of preparing the extract of chamomile, seokchangpo and choseokjam (S2), extracting sorghum Separating and filtering the fruit and ingredients (S3), fermenting the extract of chamomile, seokchangpo, choseokjam and sorghum to prepare a primary fermented liquid (S4), fermenting the primary fermented liquid to prepare a secondary fermented liquid ( S5), adding barley malt to a pile of millet and preparing millet sikhye (S6) and mixing the secondary fermentation broth and millet sikhye to prepare a functional concentrate (S7). .
본 발명의 치매 증상 예방에 도움을 줄 수 있는 인지기능 개선용 건강기능식품을 제조하기 위해 먼저, 원재료 준비단계로서 참당귀, 석창포, 초석잠, 수수 및 보리엿기름을 준비한다.(S1단계)In order to manufacture the health functional food for improving cognitive function that can help prevent dementia symptoms of the present invention, first, prepare raw material preparations such as Angelica keiskei, seokchangpo, choseokjam, sorghum and barley malt. (Step S1)
삭제delete
삭제delete
삭제delete
삭제delete
상기 참당귀, 석창포, 초석잠, 수수 및 보리엿기름을 준비한 후, 상기 참당귀, 석창포 및 초석잠을 무쇠가마솥에서 가열하여 추출액을 제조한다.(S2단계)After preparing the chamangwi, seokchangpo, choseokjam, sorghum and barley malt oil, the chamangwi, seokchangpo and choseokjam are heated in a cast iron cauldron to prepare an extract. (step S2)
이때, 상기 무쇠가마솥에서 130∼145℃의 온도로 2∼2.5시간 동안 가열하여 추출액을 제조토록 함이 바람직하다.At this time, it is preferable to prepare the extract by heating in the cast iron cauldron at a temperature of 130 to 145° C. for 2 to 2.5 hours.
그리고, 상기 수수를 세척한 후 무쇠가마솥에 볶은 다음, 100∼115℃의 온도로 1.5∼2시간 동안 가열하여 추출액과 건더기로 분리 여과한다.(S3단계)Then, after washing the sorghum, it is roasted in a cast iron cauldron, heated at a temperature of 100 to 115° C. for 1.5 to 2 hours, and separated and filtered with extract and ingredients. (Step S3)
이때, 상기 수수의 분리여과 과정에서 물과 수수를 7:3의 부피비로 혼합하여 위 조건에서 가열토록 하며, 거름망을 통해서 수수의 추출액과 건더기를 분리 여과토록 한다.At this time, in the separation filtration process of sorghum, water and sorghum are mixed in a volume ratio of 7:3 and heated under the above conditions, and the sorghum extract and ingredients are separated and filtered through a sieve.
상기 S2 및 S3단계를 통해 제조된 참당귀, 석창포, 초석잠 및 수수의 추출액을 4∼6℃에서 20∼24시간 동안 1차 저온숙성발효하여 1차발효액을 제조한다.(S4단계)A primary fermentation broth is prepared by first aging and fermenting the extracts of chamomile, seokchangpo, choseokjam and sorghum prepared through the above steps S2 and S3 at 4∼6°C for 20∼24 hours. (Step S4)
이때, 상기 S2단계 및 S3단계를 통해 제조된 추출액은 참당귀추출액 31∼37중량%, 석창포추출액 25∼34중량%, 초석잠추출액 19∼27중량% 및 수수추출액 8∼12중량%로 이루어지게 하여 본 발명의 건강기능식품을 제조토록 하였다. 이는 본 발명의 효능인 치매 증상 예방에 도움을 줄 수 있는 인지기능 개선용으로 적합한 것이다.At this time, the extract prepared through steps S2 and S3 consists of 31 to 37% by weight of chamomile extract, 25 to 34% by weight of seokchangpo extract, 19 to 27% by weight of sorghum extract and 8 to 12% by weight of sorghum extract. Thus, the health functional food of the present invention was manufactured. This is suitable for improving cognitive function that can help prevent dementia symptoms, which is the efficacy of the present invention.
그런 다음, 상기 S4단계를 통해 제조된 1차발효액을 -3∼-1℃에서 10∼13시간 동안 2차 저온냉동숙성발효하여 2차발효액을 제조한다.(S5단계)Then, the secondary fermented liquid is prepared by freezing and fermenting the primary fermented liquid prepared in step S4 at -3 to -1°C for 10 to 13 hours. (Step S5)
이때, 상기 1차발효액 및 2차발효액을 제조하는 과정에서 30분 단위로 농축을 시도하여 농축시간 및 온도를 확인하였으며, 이에 가장 적합한 시간 및 온도에 대한 조건을 얻을 수 있었다.At this time, in the process of preparing the primary and secondary fermented liquids, the concentration time and temperature were checked by concentrating every 30 minutes, and the most suitable conditions for the time and temperature were obtained.
한편, 상기 S2단계를 통해 제조된 수수건더기를 무쇠가마솥에 넣고 가열하여 수수지에밥을 지은 후, 보리엿기름을 넣고 발효하여 수수식혜를 제조한다.(S6단계)On the other hand, the millet pieces prepared in step S2 are put in a cast iron cauldron and heated to cook rice in resin, then barley malt is added and fermented to produce millet sikhye. (Step S6)
이때, 상기 S6단계의 수수식혜를 제조하는 단계에서 수수지에밥 100중량부를 기준으로 보리엿기름 21∼25중량부를 혼합한 후, 58∼63℃에서 8∼10시간 동안 발효하여 수수식혜를 제조하도록 한다.At this time, in the step of manufacturing sorghum sikhye in step S6, 21 to 25 parts by weight of barley malt is mixed based on 100 parts by weight of rice in the resin, and then fermented at 58 to 63° C. for 8 to 10 hours to prepare sorghum sikhye.
그리고, 상기 S5단계를 통해 제조된 2차발효액과 S6단계를 통해 제조된 수수식혜를 여과하여 혼합한 후, 75∼85℃의 온도로 7∼10시간 동안 가열하여 기능성 농축액을 제조한다.(S7단계)Then, the secondary fermentation broth prepared in step S5 and sorghum sikhye prepared in step S6 are filtered and mixed, and then heated at a temperature of 75 to 85° C. for 7 to 10 hours to prepare a functional concentrate. (S7 step)
상기와 같은 S1∼S7단계를 통해 제조된 기능성 농축액을 도 2에서와 같이 스틱형 포장지에 일정량 투입 포장하여 스틱형 건강기능식품을 제조하도록 구성할 수 있다.As shown in FIG. 2, the functional concentrate prepared through steps S1 to S7 as described above is put in a predetermined amount in a stick-type packaging paper and packaged to produce a stick-type health functional food.
또한, 다른 실시예로서 상기 기능성 농축액에 수수가루를 혼합, 발효하여 강정과 양갱 중간형태의 디저트형 건강기능식품을 제조하도록 구성할 수 있다. 이때에는 상기 기능성 농축액 100중량부를 기준으로 수수가루 30∼32중량부를 혼합한 후, 40∼43℃의 온도에서 12∼14시간 동안 발효한 다음, 5∼8℃의 온도에서 6∼7시간 동안 저온건조하여 완성되도록 함이 바람직하다.In addition, as another embodiment, by mixing and fermenting sorghum powder in the functional concentrate, it can be configured to produce a dessert-type health functional food intermediate between gangjeong and yanggaeng. At this time, after mixing 30 to 32 parts by weight of sorghum powder based on 100 parts by weight of the functional concentrate, fermented at a temperature of 40 to 43° C. for 12 to 14 hours, and then low temperature at a temperature of 5 to 8° C. for 6 to 7 hours. It is preferable to dry it so that it is finished.
상술된 바와 같은 본 발명의 면연력 감소 및 치매 증상 예방에 도움을 줄 수 있는 인지기능 개선용 건강기능식품의 제조방법에 의해 제조되는 건강기능식품은 일실시예로서, 참당귀, 석창포 및 초석잠을 무쇠가마솥에서 130∼145℃의 온도로 2∼2.5시간 동안 가열하여 얻은 추출액과, 수수를 세척한 후 무쇠가마솥에 볶은 다음, 100∼115℃의 온도로 1.5∼2시간 동안 가열하여 얻은 추출액을 4∼6℃에서 20∼24시간 동안 1차 저온숙성발효하여 1차발효액을 제조하고, 상기 1차발효액을 -3∼-1℃에서 10∼13시간 동안 2차 저온냉동숙성발효하여 2차발효액을 제조하며, 수수를 세척한 후 무쇠가마솥에 볶은 다음, 100∼115℃의 온도로 1.5∼2시간 동안 가열한 후 얻은 추출액을 제외한 수수건더기를 무쇠가마솥에 넣고 가열하여 수수지에밥을 지은 후, 보리엿기름을 넣고 발효하여 수수식혜를 제조하고, 상기 2차발효액과 수수식혜를 각각 여과하여 혼합한 후, 75∼85℃의 온도로 7∼10시간 동안 가열하여 기능성 농축액을 제조하며, 상기 기능성 농축액을 스틱형 포장지에 일정량 투입 포장하여 스틱형 건강기능식품을 제조하도록 구성한다.The health functional food prepared by the method of manufacturing a health functional food for cognitive function improvement that can help to reduce immunity and prevent dementia symptoms of the present invention as described above is an embodiment, The extract obtained by heating in a cast iron cauldron at a temperature of 130 to 145 ° C for 2 to 2.5 hours, and the extract obtained by washing the millet and roasting it in a cast iron cauldron, then heating it at a temperature of 100 to 115 ° C for 1.5 to 2 hours. The primary fermented liquid is prepared by first low-temperature aging and fermentation at 4 to 6 ℃ for 20 to 24 hours, and the secondary fermented liquid is fermented by second low-temperature freeze aging and fermentation at -3 to -1 ℃ for 10 to 13 hours. After washing the sorghum and frying it in a cast iron cauldron, heat it at a temperature of 100 to 115 ° C for 1.5 to 2 hours. Add malt and ferment to prepare sorghum sikhye, filter and mix the secondary fermented liquid and sorghum sikhye, respectively, and heat at a temperature of 75 to 85° C. for 7 to 10 hours to prepare a functional concentrate, and the functional concentrate It is configured to manufacture a stick-type health functional food by packing a certain amount in a stick-type packaging paper.
다른 실시예로서, 참당귀, 석창포 및 초석잠을 무쇠가마솥에서 130∼145℃의 온도로 2∼2.5시간 동안 가열하여 얻은 추출액과, 수수를 세척한 후 무쇠가마솥에 볶은 다음, 100∼115℃의 온도로 1.5∼2시간 동안 가열하여 얻은 추출액을 4∼6℃에서 20∼24시간 동안 1차 저온숙성발효하여 1차발효액을 제조하고, 상기 1차발효액을 -3∼-1℃에서 10∼13시간 동안 2차 저온냉동숙성발효하여 2차발효액을 제조하며, 수수를 세척한 후 무쇠가마솥에 볶은 다음, 100∼115℃의 온도로 1.5∼2시간 동안 가열한 후 얻은 추출액을 제외한 수수건더기를 무쇠가마솥에 넣고 가열하여 수수지에밥을 지은 후, 보리엿기름을 넣고 발효하여 수수식혜를 제조하고, 상기 2차발효액과 수수식혜를 각각 여과하여 혼합한 후, 75∼85℃의 온도로 7∼10시간 동안 가열하여 기능성 농축액을 제조하며, 상기 기능성 농축액에 수수가루를 혼합, 발효하여 강정과 양갱 중간형태의 디저트형 건강기능식품을 제조하도록 구성한다.As another example, after washing the extract obtained by heating chamsanggui, seokchangpo and choseokjam in a cast iron cauldron at a temperature of 130 to 145° C. for 2 to 2.5 hours, and sorghum, roasted in a cast iron cauldron, and then at The extract obtained by heating at a temperature of 1.5 to 2 hours is subjected to primary low-temperature aging and fermentation at 4 to 6 ° C. for 20 to 24 hours to prepare a primary fermented liquid, and the primary fermented liquid is heated at -3 to -1 ° C for 10 to 13 The second fermented liquid is prepared by the second low-temperature freeze-aging fermentation for a period of time, and after washing the millet and roasting it in a cast iron cauldron, it is heated at a temperature of 100 to 115 ° C for 1.5 to 2 hours. Put it in a cauldron and heat it to cook rice in resin, then add barley malt and ferment it to prepare sorghum sikhye, filter and mix the secondary fermented liquid and sorghum sikhye, respectively, and then at a temperature of 75 to 85 ° C for 7 to 10 hours. A functional concentrate is prepared by heating, and sorghum powder is mixed and fermented in the functional concentrate to produce a dessert-type health functional food intermediate between gangjeong and yanggaeng.
이때, 상기 1차발효액을 제조하는 추출액은 참당귀추출액 31∼37중량%, 석창포추출액 25∼34중량%, 초석잠추출액 19∼27중량% 및 수수추출액 8∼12중량%로 이루어지도록 하고, 또한 상기 수수식혜는 수수지에밥 100중량부를 기준으로 보리엿기름 21∼25중량부를 혼합한 후, 58∼63℃에서 8∼10시간 동안 발효하여 제조되도록 구성하는 것이 바람직하다.At this time, the extract for preparing the primary fermented solution consists of 31 to 37% by weight of Angelica larvae extract, 25 to 34% by weight of seokchangpo extract, 19 to 27% by weight of sorghum extract and 8 to 12% by weight of sorghum extract, and It is preferable that the sorghum sikhye is prepared by mixing 21 to 25 parts by weight of barley malt based on 100 parts by weight of sorghum and rice, and then fermenting it at 58 to 63° C. for 8 to 10 hours.
상술된 바와 같은 본 발명의 면연력 감소 및 치매 증상에 도움을 줄 수 있는 인지기능 개선용 건강기능식품의 제조방법 및 그 건강기능식품에 의하면, 기억력 증진 및 항산화에 효과가 있다고 알려진 참당귀, 석창포, 초석잠, 수수, 보리엿기름에 포함된 유효성분을 극대화하여 항산화, 기억력 증진, 치매예방에 도움을 줄 수 있게 되고, 또한, 치매의 주요 증상인 기억력 감퇴 및 인지능력을 개선하는데 효능이 있는 재료를 활용하여 스틱형 및 스낵 형태로 된 건강기능제품을 개발함으로써 소비자가 일상생활에서 편하게 섭취할 수 있게 된다.According to the method for manufacturing a health functional food for improving cognitive function that can help reduce immunity and symptoms of dementia of the present invention as described above, and the health functional food, it is known that it is effective in improving memory and antioxidant. By maximizing the active ingredients contained in , sorghum, sorghum, and barley malt, it is possible to help antioxidant, memory enhancement, and dementia prevention. By developing health functional products in the form of sticks and snacks by utilizing
이상에서 설명한 본 발명은, 도면에 도시된 일실시 예를 참고로 설명되었으나 이는 예시적인 것에 불과하며, 본 기술 분야의 통상의 지식을 가진 자라면 이로부터 다양한 변형 및 균등한 타 실시 예가 가능하다는 점을 명확히 하여야 할 것이다. 따라서, 본 발명의 진정한 기술적 보호 범위는 첨부된 청구범위에 의하여 해석되어야 하며, 그와 동등한 범위 내에 있는 모든 기술적 사상은 본 발명의 권리범위에 포함되는 것으로 해석되어야 할 것이다.Although the present invention described above has been described with reference to one embodiment shown in the drawings, this is merely exemplary, and various modifications and equivalent other embodiments are possible by those skilled in the art. should be made clear. Accordingly, the true technical protection scope of the present invention should be construed by the appended claims, and all technical ideas within the scope equivalent thereto should be construed as being included in the scope of the present invention.
Claims (10)
상기 S2단계 및 S3단계를 통해 제조된 추출액은 참당귀추출액 31∼37중량%, 석창포추출액 25∼34중량%, 초석잠추출액 19∼27중량% 및 수수추출액 8∼12중량%로 이루어지고,
상기 S6단계의 수수식혜를 제조하는 단계에서 수수지에밥 100중량부를 기준으로 보리엿기름 21∼25중량부를 혼합한 후, 58∼63℃에서 8∼10시간 동안 발효하여 수수식혜를 제조하며,
상기 S7단계를 통해 제조된 기능성 농축액에 수수가루를 혼합, 발효하여 강정과 양갱 중간형태의 디저트형 건강기능식품을 제조하되,
상기 디저트형 건강기능식품을 제조 시, 상기 기능성 농축액 100중량부를 기준으로 수수가루 30∼32중량부를 혼합한 후, 40∼43℃의 온도에서 12∼14시간 동안 발효한 다음, 5∼8℃의 온도에서 6∼7시간 동안 저온건조하여 완성되도록 구성하는 것을 특징으로 하는 치매 증상 예방에 도움을 줄 수 있는 인지기능 개선용 건강기능식품의 제조방법.
Raw material preparation step (S1) of preparing chamanggui, seokchangpo, choseokjam, sorghum and barley malt; Preparing the extract (S2) by heating the chamomile, seokchangpo and choseokjam in a cast iron cauldron at a temperature of 130 to 145° C. for 2 to 2.5 hours; After washing the sorghum, roasting it in a cast iron cauldron, heating it at a temperature of 100 to 115° C. for 1.5 to 2 hours, and separating and filtering the extract and the ingredients (S3); Preparing a primary fermented liquid by first aging and fermenting the extracts of Angelica keiskei, seokchangpo, choseokjam and sorghum prepared through the steps S2 and S3 at 4 to 6° C. for 20 to 24 hours (S4); preparing a secondary fermented liquid by secondary low-temperature freeze-aging fermentation of the primary fermented liquid prepared in step S4 at -3 to -1°C for 10 to 13 hours (S5); Putting the millet pieces prepared in step S3 in a cast iron cauldron and heating to cook rice in resin, then adding barley malt and fermenting to prepare millet sikhye (S6); After filtering and mixing the secondary fermented liquid and sorghum sikhye, respectively, heating at a temperature of 75 to 85 ° C. for 7 to 10 hours to prepare a functional concentrate (S7); In the method for manufacturing a health functional food for improving cognitive function,
The extract prepared through steps S2 and S3 consists of 31 to 37% by weight of Angelica persimmon extract, 25 to 34% by weight of seokchangpo extract, 19 to 27% by weight of oleracea extract and 8 to 12% by weight of sorghum extract,
In the step of preparing sorghum sikhye in step S6, 21-25 parts by weight of barley malt is mixed based on 100 parts by weight of sorghum and rice, and then fermented at 58-63° C. for 8-10 hours to prepare sorghum sikhye,
By mixing and fermenting sorghum powder in the functional concentrate prepared through step S7, a dessert-type health functional food intermediate between gangjeong and yanggaeng is produced,
When manufacturing the dessert-type health functional food, 30 to 32 parts by weight of sorghum powder is mixed based on 100 parts by weight of the functional concentrate, and then fermented at a temperature of 40 to 43 ° C. for 12 to 14 hours, and then at 5 to 8 ° C. A method of manufacturing a health functional food for improving cognitive function that can help prevent dementia symptoms, characterized in that it is completed by drying at low temperature for 6-7 hours at a temperature.
A health functional food for improving cognitive function that can help prevent dementia symptoms, characterized in that it is manufactured by the manufacturing method of the health functional food of claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190105027A KR102286593B1 (en) | 2019-08-27 | 2019-08-27 | Manufacturing method of health functional food for cognitive function improvement that can help prevent dementia symptoms and health functional food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190105027A KR102286593B1 (en) | 2019-08-27 | 2019-08-27 | Manufacturing method of health functional food for cognitive function improvement that can help prevent dementia symptoms and health functional food |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210025256A KR20210025256A (en) | 2021-03-09 |
KR102286593B1 true KR102286593B1 (en) | 2021-08-04 |
Family
ID=75179978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190105027A KR102286593B1 (en) | 2019-08-27 | 2019-08-27 | Manufacturing method of health functional food for cognitive function improvement that can help prevent dementia symptoms and health functional food |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102286593B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102379258B1 (en) | 2021-08-17 | 2022-03-29 | 재단법인 포항테크노파크 | Manufacturing method of health functional food containing hempseeds |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102582249B1 (en) * | 2022-09-27 | 2023-09-25 | 강위희 | A Brain health nutritional supplement manufacturing method using natural herbs and Stachys affinis |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101551304B1 (en) * | 2015-04-17 | 2015-09-10 | 임종식 | Attractive pill using Polygala radix and Acori Graminei Rhizoma and making method of it |
KR102003635B1 (en) | 2018-02-06 | 2019-07-24 | 경남대학교 산학협력단 | Extraction method using Angelica gigas Nakai and stachys sieboldii |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101804212B1 (en) | 2014-12-03 | 2017-12-06 | 우석대학교 산학협력단 | Ecklonia stolonifera for the improvement of memory and cognition ability, prevention delay or treatment of Alzheimer's disease, pharmaceutical composition containing the extracts and supplementary Food containing the extracts |
KR101970659B1 (en) * | 2016-11-10 | 2019-04-19 | 성삼섭 | A Manufacturing Method of Concentrate having antioxidant activity |
-
2019
- 2019-08-27 KR KR1020190105027A patent/KR102286593B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101551304B1 (en) * | 2015-04-17 | 2015-09-10 | 임종식 | Attractive pill using Polygala radix and Acori Graminei Rhizoma and making method of it |
KR102003635B1 (en) | 2018-02-06 | 2019-07-24 | 경남대학교 산학협력단 | Extraction method using Angelica gigas Nakai and stachys sieboldii |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102379258B1 (en) | 2021-08-17 | 2022-03-29 | 재단법인 포항테크노파크 | Manufacturing method of health functional food containing hempseeds |
Also Published As
Publication number | Publication date |
---|---|
KR20210025256A (en) | 2021-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102286593B1 (en) | Manufacturing method of health functional food for cognitive function improvement that can help prevent dementia symptoms and health functional food | |
US10376552B2 (en) | Memory improving composition comprising arillus longan, semen nelumbinis, poria and semen juglandis | |
CN102159228A (en) | Composition comprising a hot water extract of hemerocallis plants, said composition being effective in treating fatigue by having antidepressant properties or by improving sleep | |
Chen et al. | Kefir extracts suppress in vitro proliferation of estrogen-dependent human breast cancer cells but not normal mammary epithelial cells | |
CN102965237B (en) | Mulberry-ganoderma fruit wine and production method thereof | |
CN102293282B (en) | Glede tea beverage and preparation method thereof | |
CN101168025B (en) | Medicine composition for preventing and treating senile dementia | |
Narayana et al. | Chyawanprash: A review of therapeutic benefits as in authoritative texts and documented clinical literature | |
CN102791849A (en) | Lactic acid bacterium-containing preparation | |
CN110432414A (en) | A kind of Dendrobidium huoshanness combined beverage and preparation method thereof adjusting function of human body | |
CN104922164A (en) | Composite medicine preparation for treating alzheimer disease | |
JP2023164630A (en) | Oral composition | |
CN103284035B (en) | Health-care oil tea honey | |
CN106987504A (en) | A kind of production method of yellow rice wine | |
CN105316208A (en) | Anti-aging vinegar | |
JP2008050331A (en) | New dietary composition useful for dementia | |
CN105477225B (en) | Traditional Chinese veterinary medicine for enhancing anti-stress capability of chicks, preparation method and feeding method | |
CN106666746A (en) | Asparagus composition with neurotransmitter balance adjusting function and preparation method thereof as well as asparagus composition powder | |
KR20180050331A (en) | Honkiol and Magnolol Formulations Having Increased Stability and Improved Absorbency, and Methods of Using Them | |
CN114794491A (en) | Composition for improving brain function and preparation method thereof | |
JP3761510B2 (en) | Foods that improve or prevent hay fever | |
CN101040863B (en) | Medicine monocase compound for treating alzheimers disease | |
CN105876008A (en) | Health-care liquid tea drink | |
CN113134024A (en) | Application of dandelion water extract in preparation of composition for promoting fat metabolism and water metabolism | |
CN105327331A (en) | Composition for treating and preventing senile dementia and preparation method and application of composition for treating and preventing senile dementia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |